(Q47962016)

English

Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease

scientific article published in April 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

author name string

S Webster

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

M R Emmerling

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

De Lima N

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

A E Roher

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

Biochimica et Biophysica Acta

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

1406

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

291-298

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

pH-dependent structural transitions of Alzheimer amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The immunoreactive profile at the N-terminal region of A beta 1-39/40 but not A beta 1-42 changes with transition from monomer/dimer to further peptide aggregates

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of aspartic acid-bond isomerization on in vitro properties of the amyloid beta-peptide as modeled with N-terminal decapeptide fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2898%2900014-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0925-4439(98)00014-3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9630681

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47962016&oldid=2178377926"